Alphabet-backed start-up Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine. Johnson & Johnson's Janssen Biotech unit is the ...

The JavaScript innovation train is really picking up momentum lately, driven—as always—by the creativity of the JavaScript developer community. The emerging local-first SQL datastores crystalize ideas ...

The thick client is making a comeback. Here’s how next-generation local databases like PGlite and RxDB are bringing feature-rich data storage to the browser. Once upon a time, we had mainframes with ...

After presenting comparable docking results last year—and using them to prospectively identify drug candidates on difficult targets—Deep Origin welcomes Isomorphic Labs to the frontier SOUTH SAN ...

Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says outperforms AlphaFold 3. According to the company, ...

The most visible impact of AI seems to be in coding, but it could also be poised to disrupt other hard sciences. Isomorphic Labs, a drug discovery subsidiary of Google’s parent company Alphabet, ...

Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.

Jan 20 (Reuters) - Isomorphic Labs, ‌which uses artificial intelligence ‌for drug discovery, expects to have its first clinical trials by the ‍end of 2026, founder and CEO Demis Hassabis said ⁠on ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical ‌trials by the end of 2026, founder and CEO ‌Demis Hassabis said on ...

In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s secretive drug discovery arm, Isomorphic Labs, is getting ready to ...